Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The overall aim of the proposed study is to determine whether whole body vibration is beneficial in promoting bone health, physical fitness and neuromotor performance in patients with chronic stroke.
Subjects in the experimental group will undergo whole body vibration therapy (1 session per day, 3 sessions per week) for 8 weeks. The vibration frequency used in this study will be 30Hz. The total duration of exposure to vibration for the experimental group will be 10 minutes. While standing on the vibration platform, patients will be instructed to repeat the following set of light exercises: (1) light squatting,(2) deep squatting, (3) side-to-side weight-shift, (4) Forward and backward weight-shift, (5) forward lunge, (6) marching on the spot. The control exercise group, on the other hand, will perform the same exercise program on the platform, but no vibration will be given. The training will be conducted by a qualified personnel with physiotherapy background.
The outcome measurement will be performed 4 times: (1) immediately before the commencement of intervention, (2) immediately after termination of treatment, (3) at 1 month after termination of treatment. Each subject will be evaluated for bone markers, leg muscle strength, balance, spasticity, and walking ability.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Active Comparator | The control group will perform the same exercises on the vibration platform, as in the experimental group. However, the vibration device will be turned off during the exercises. |
|
| Whole body vibration | Experimental | Subjects in the experimental group will undergo whole body vibration (1 session per day, 3 sessions per week) for 8 weeks. The vibration loading will be carried out using the Jet-Vibe System (Danil SMC Co., Ltd., Seoul, Korea). The vibration protocol used in this study will be 30Hz. While standing on the vibration platform, patients will be instructed to repeat the following set of light exercises: (1) light squatting,(2)deep squatting , (3) side-to-side weight-shift, (4) Forward and backward weight-shift, (5) forward lunge, (6) marching on the spot. The total duration of exposure of whole body vibration per session will be about 10 minutes. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Whole body vibration therapy | Device | Experimental group: One session per day, 3 sessions per week, for consecutive 8 weeks. The total duration of whole body vibration therapy will be about 10 minutes per session. |
| Measure | Description | Time Frame |
|---|---|---|
| Paretic knee concentric muscle strength | pre-test (week 0) | |
| Paretic knee concentric muscle strength | Post-test (week 8) | |
| Paretic knee concentric muscle strength | Follow-up (week 12) |
| Measure | Description | Time Frame |
|---|---|---|
| Non-paretic concentric knee muscle strength | Pre-test (week 0) | |
| Non-paretic knee concentric muscle strength | Post-test (week 8) | |
| Non-paretic knee concentric muscle strength |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marco YC Pang, PhD | The Hong Kong Polytechnic University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hong Kong Polytechnic University | Hong Kong | China |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Exercise on the vibration platform with the device turned off | Device | Control group: One session per day, 3 sessions per week, for consecutive 8 weeks. The subjects will perform the same exercises on the vibration platform but no vibration will be applied. |
|
|
| Follow-up (week 12) |
| Paretic knee eccentric muscle strength | pre-test (week 0) |
| Paretic knee eccentric muscle strength | Post-test (week 8) |
| Paretic knee eccentric muscle strength | WFollow-up (week 12) |
| Non-paretic knee eccentric muscle strength | Pre-test (week 0) |
| Non-paretic knee eccentric muscle strength | Post-test (week 8) |
| Non-paretic knee eccentric muscle strength | Follow-up (week 12) |
| Paretic knee isometric muscle strength | Pre-test (week 0) |
| Paretic knee isometric muscle strength | Post-test (week 8) |
| Paretic knee isometric muscle strength | Follow-up (week 12) |
| Non-paretic knee isometric muscle strength | Pre-test (week 0) |
| Non-paretic knee isometric muscle strength | Post-test (week 8) |
| Non-paretic knee isometric muscle strength | Follow-up (week 12) |
| Limit of stability test | Pre-test (week 0) |
| Limit of stability test | Post-test (week 8) |
| Limit of stability test | Follow-up (week 12) |
| Berg balance test | Pre-test (week 0) |
| Berg balance test | Post-test (week 12) |
| Berg balance test | Follow-up (week 12) |
| Activities-specific Balance Confidence Scale | Pre-test (week 0) |
| Activities-specific Balance Confidence Scale | Post-test (week 8) |
| Activities-specific Balance Confidence Scale | Follow-up (week 12) |
| Six Minute Walk Test | Pre-test (week 0) |
| Six Minute Walk Test | Post-test (week 8) |
| Six Minute Walk Test | Follow-up (week 12) |
| Self-selected gait velocity | Pre-test (week 0) |
| Self-selected gait velocity | post-test (week 8) |
| Self-selected gait velocity | Follow-up (week 12) |
| Bone formation marker level | pre-test (week 0) |
| Bone formation marker level | Post-test (week 8) |
| Bone resorption marker level | pre-test (week 0) |
| Bone formation marker level | Follow-up (week 12) |
| Bone resorption marker level | post-test (week 8) |
| Bone resorption marker level | Follow-up (week 12) |
| fall rate | 6 months after termination of treatment |
| Knee spasticity | Pre-test (week 0) |
| Knee spasticity | Post-test (week 8) |
| Knee spasticity | Follow-up (week 12) |
| Ankle spasticity | Pre-test (week 0) |
| Ankle spasticity | Post-test (week 8) |
| Ankle spasticity | Follow-up (week 12) |
| Level of satisfaction | Post-test (week 8) |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |